Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
- 1 December 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 141, 84-91
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hypoxia as a biomarker for radioresistant cancer stem cellsInternational Journal of Radiation Biology, 2014
- Hypoxia Enhances the Radioresistance of Mouse Mesenchymal Stromal CellsStem Cells, 2014
- Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivoEuropean Journal of Medicinal Chemistry, 2013
- Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domainEuropean Journal of Medicinal Chemistry, 2013
- Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell lineBiochemical and Biophysical Research Communications, 2008
- Structure-Based View of Epidermal Growth Factor Receptor RegulationAnnual Review of Biophysics, 2008
- Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer InterfaceMolecular and Cellular Biology, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB ReceptorsMolecular Cell, 2003